Institut National de la Santé et de la Recherche Médicale (INSERM)
发明人:
申请号：
EP09772441.3
公开号：
EP2313432B1
申请日:
2009.06.30
申请国别(地区):
EP
年份:
2017
代理人:
摘要：
The present invention stems from the finding that the extracellular domain of CD31 proteins present on blood leukocytes is shed and released in the circulation as a soluble form of CD31. The invention relates to peptides corresponding to fragments of CD31 that inhibit T-cell response, and to their use in the treatment of thrombotic disorders such as atherothrombosis and autoimmune disorders.
